BETi-211

BETi-211 is an orally active, selective BET inhibitor with a Ki < 1 nM. BETi-211 inhibits BET function as epigenetic readers by binding to BET proteins (BRD2, BRD3, and BRD4). BETi-211 suppresses the growth of various triple-negative breast cancer (TNBC) cell lines, with an IC50 < 1 μM. BETi-211 can be utilized to synthesize PROTAC molecules designed to degrade BET proteins. BETi-211 is applicable for research into TNBC.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • CAS No.: 1995867-02-1
  • 화학식: C26H29N7O3
  • 분자량:487.55
  • 보관:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocol
  • 순도&문서
  • References
  • Help & FAQs

All Epigenetic Reader Domain Isoforms

More
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00